Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 8 Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 13 Rectal Neoplasms 10 Colorectal Neoplasms 10 Stomach Neoplasms 3 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Recurrence 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Microbiota 1 Gallbladder Neoplasms 1 Fruquintinib 1 Elderly Metastatic Colorectal Cancer Patients 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Cancer Organoids 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

Fluorodeoxyglucose F18 3 Blood Specimen Collection 2 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 Tegafur 1 Surveys and Questionnaires 1 Specimen Handling 1 S 1 (combination) 1 Radiomics 1 Proton Therapy 1 Postmortem Imaging 1 PMEPA1 protein, human 1 Off-Label Use 1 Latent Class Analysis 1 Immunohistochemistry 1 Histocompatibility Testing 1 Hepatitis B Vaccines 1 Fluorouracil 1 Capecitabine 1 Blood Component Removal 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Solid Tumor × Capecitabine × Clear all

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡